S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Kraton Performance Polymers, Inc. Announces Third Quarter 2014 Earnings Release Conference Call and Webcast|
|Kraton And Rosneft Deliver Formula One Pavement Solution|
|Building Better Roads: Highly Modified Asphalt (HiMA) Technology Reduces Overall Cost, Lessens Road Damage Over Time|
|Kraton Performance Polymers, Inc. Announces Third Quarter 2014 Results And Board Approval Of $50 Million Share Repurchase Program|
|Trovagene Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients|
|Oncolytics Biotech® Inc. Announces Overall and KRAS-Mutated Patient Data from U.S. Randomized Phase 2 Pancreatic Cancer Study (2014/9/16)|
|BIND Therapeutics Presents Positive Phase 2 Results Highlighting Potential of BIND-014 as Novel Anti-Cancer Treatment at Q3W Dosing Schedule for Patients with Non-small Cell Lung Cancer at 26th EORTC-NCI-AACR Annual Symposium|
|Oncolytics Biotech® Inc. Announces Third Quarter 2014 Results (2014/11/6)|
|Rosetta Genomics Partners with Admera Health for the Commercialization of Current and Future Sequencing-Based Oncology Tests|
|Five Prime Therapeutics Appoints Dr. Robert Sikorski as Vice President of Global Clinical Development|
Click above to view more mutual fund data and stats for kra - Kraton Performance Polymers Inc.